Advertisement
BNBX vs PRPO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNBX is a Hold and PRPO is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BNBX’s FA Score shows that 0 FA rating(s) are green whilePRPO’s FA Score has 1 green FA rating(s).
- BNBX’s FA Score: 0 green, 5 red.
- PRPO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BNBX’s TA Score shows that 4 TA indicator(s) are bullish while PRPO’s TA Score has 4 bullish TA indicator(s).
- BNBX’s TA Score: 4 bullish, 6 bearish.
- PRPO’s TA Score: 4 bullish, 3 bearish.
Price Growth
BNBX (@Investment Managers) experienced а -3.22% price change this week, while PRPO (@Medical Specialties) price change was +3.59% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -2.28%. For the same industry, the average monthly price growth was -2.46%, and the average quarterly price growth was -8.13%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.45%. For the same industry, the average monthly price growth was +2.48%, and the average quarterly price growth was -3.19%.
Industries' Descriptions
@Investment Managers (-2.28% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Medical Specialties (+0.45% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BNBX | PRPO | BNBX / PRPO | |
| Capitalization | 3.2M | 41.5M | 8% |
| EBITDA | -25M | 933K | -2,679% |
| Gain YTD | -63.805 | 1.153 | -5,533% |
| P/E Ratio | 0.00 | N/A | - |
| Revenue | 2.09M | 25.8M | 8% |
| Total Cash | 949K | 2.6M | 36% |
| Total Debt | 0 | 3.49M | - |
BNBX | PRPO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 94 | |
PRICE GROWTH RATING 1..100 | 92 | 51 | |
P/E GROWTH RATING 1..100 | 55 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRPO's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for BNBX (65) in the Information Technology Services industry. This means that PRPO’s stock grew somewhat faster than BNBX’s over the last 12 months.
PRPO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BNBX (100) in the Information Technology Services industry. This means that PRPO’s stock grew similarly to BNBX’s over the last 12 months.
PRPO's SMR Rating (94) in the Biotechnology industry is in the same range as BNBX (100) in the Information Technology Services industry. This means that PRPO’s stock grew similarly to BNBX’s over the last 12 months.
PRPO's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for BNBX (92) in the Information Technology Services industry. This means that PRPO’s stock grew somewhat faster than BNBX’s over the last 12 months.
BNBX's P/E Growth Rating (55) in the Information Technology Services industry is somewhat better than the same rating for PRPO (100) in the Biotechnology industry. This means that BNBX’s stock grew somewhat faster than PRPO’s over the last 12 months.
| BNBX | PRPO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 90% | N/A |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 86% |
| Advances ODDS (%) | 8 days ago 76% | 2 days ago 81% |
| Declines ODDS (%) | 12 days ago 90% | 7 days ago 85% |
| BollingerBands ODDS (%) | 2 days ago 85% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 86% |
Advertisement
BNBX and
Correlation & Price change
A.I.dvisor tells us that BNBX and UFPT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNBX and UFPT's prices will move in lockstep.
| Ticker / NAME | Correlation To BNBX | 1D Price Change % | ||
|---|---|---|---|---|
| BNBX | 100% | +10.42% | ||
| UFPT - BNBX | 29% Poorly correlated | -2.50% | ||
| AGPU - BNBX | 28% Poorly correlated | +0.28% | ||
| CODX - BNBX | 28% Poorly correlated | -7.42% | ||
| PRPO - BNBX | 27% Poorly correlated | +3.54% | ||
| RJF - BNBX | 26% Poorly correlated | +0.51% | ||
More | ||||
PRPO and
Correlation & Price change
A.I.dvisor tells us that PRPO and BNBX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPO and BNBX's prices will move in lockstep.
| Ticker / NAME | Correlation To PRPO | 1D Price Change % | ||
|---|---|---|---|---|
| PRPO | 100% | +3.54% | ||
| BNBX - PRPO | 27% Poorly correlated | +10.42% | ||
| VTAK - PRPO | 27% Poorly correlated | +3.54% | ||
| TNON - PRPO | 27% Poorly correlated | +77.57% | ||
| INGN - PRPO | 25% Poorly correlated | +0.47% | ||
| XAIR - PRPO | 25% Poorly correlated | +8.61% | ||
More | ||||